SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 223 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7149Corbus (CRBP) up 19% on no news whatsoever. POC data readout in a month, followtuck-10/5/2016
7148Giving it back today. I read "anticipated" questions as those involvescaram(o)uche-10/4/2016
7147DVAX so far, guess they got some questions from the FDA...mopgcw-10/3/2016
7146Catabasis Pharmaceuticals and Sarepta Therapeutics Announce a Joint Research ColJulius Wong-9/29/2016
7145Aegerion Pharmaceuticals' JUXTAPID® (lomitapide) Capsules Approved in JJulius Wong-9/29/2016
7144Anavex Compound to be Tested in Biogen Neurological Protection Model finance.yaJulius Wong-9/28/2016
7143You may be right—I'm actually not sure. I've seen other small biotechs mDewDiligence_on_SI19/22/2016
7142Wouldn't the more likely reason be the Stop-ALF PR and anticipation of data?ghmm-9/22/2016
7141OCRX +15% on new slide set* and consequent spirited debate on Twitter (seriouslyDewDiligence_on_SI-9/22/2016
7140RVNC +15% on no news, but: siliconinvestor.comDewDiligence_on_SI-9/16/2016
7139Was blown away by the current literature and indication hints, hadn't lookedscaram(o)uche-9/15/2016
7138The management execution leaves a lot to be desired but it looks like Scenesse mghmm-9/15/2016
7137Wow. How cool. An indication exists for a melanocortin-1 receptor agonist? Vescaram(o)uche-9/15/2016
7136$CLVLY / $CLVLF is up around 20% today in Australian it was up around 15% on reaghmm-9/15/2016
7135Lexicon Pharma shares rally premarket on positive trial of diabetes treatment Julius Wong-9/9/2016
7134Sept 7 (Reuters) - Retrophin Inc (RTRX) said its rare kidney disorder drug met tJulius Wong-9/7/2016
7133CPHD 50%; bid. <i>Washington, D.C.-based Danaher, which traces its originnigel bates-9/6/2016
7132CLCD +67% on phase-3 migraine data from SAMURAI study: siliconinvestor.comDewDiligence_on_SI-9/6/2016
7131CYNA, CTH.TO +115% on buy out: by bytnsaf-9/1/2016
7130STEM +628% on reverse merger: siliconinvestor.com (see bottom).DewDiligence_on_SI-8/16/2016
7129NVS has a selling plan: siliconinvestor.com siliconinvestor.comDewDiligence_on_SI-8/15/2016
7128flush!Land Shark-8/15/2016
7127EGRX +19% on Ryanodex news (and 2Q16 financials): siliconinvestor.com siliconiDewDiligence_on_SI-8/9/2016
7126MNTA—Make that +27%.DewDiligence_on_SI-8/5/2016
7125MNTA +16% on no new I'm aware of; it does, however, have a lot of upcoming nDewDiligence_on_SI18/5/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News